Tip: Index histories & All-time highs

Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Wed, 22.01.2025       Relief Therapeutics Holding SA
CH1251125998

Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE® Rights ex-USSale of GOLIKE® Rights Outside the U.S. to Nutrisens Relief to Focus on R&D of Pipeline Assets and Licensing for Commercialized Products GENEVA (JAN. 22, 2025) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharm [ … ]
Technical analysis
To the publication
Wed, 22.01.2025       Schoeller-Bleckmann Oilfield Equipment AG
AT0000946652

Preliminary results 2024: SBO with strong cash generation and solid results despite challenging market conditions Ternitz/Vienna, 22 January 2025. Schoeller-Bleckmann Oilfield Equipment AG (SBO), listed in the leading ATX index of the Vienna Stock Exchange, today announced its preliminary results for the financial year 2024. Despite a challenging  [ … ]
Technical analysis
To the publication
Wed, 22.01.2025       Cicor Technologies Ltd
CH0008702190

Cicor Technologies Ltd / Key word(s): Statement Statement on media report 22.01.2025 / 07:00 CET/CEST Media Release Bronschhofen, January 22, 2025 – Following a recent article in the French media, Cicor Group (SIX Swiss Exchange: CICN) indicates that it is in discussions with the company Éolane France and relevant governmental [ … ]
Technical analysis
To the publication
Tue, 21.01.2025       Schaeffler AG
DE000SHA0019

Disclosure of an inside information according to Article 17 MAR of the Regulation (EU) No 596/2014   Schaeffler AG: Based on preliminary figures, EBIT margin before special items for fiscal year 2024 below group guidance Herzogenaurach, 21 January 2025 – Schaeffler AG (DE000SHA0019) releases results for fiscal year 2024 based on preliminary and  [ … ]
Technical analysis
To the publication
Tue, 21.01.2025       adidas AG
DE000A1EWWW0

FOR IMMEDIATE RELEASEHerzogenaurach, January 21, 2025 adidas finishes successful year with better-than-expected fourth quarter results adidas today announced preliminary results for the fourth quarter of 2024. In Q4, currency-neutral revenues increased 19%. In euro terms, the company’s revenues grew 24% to € 5,965 million (2023: € 4,812 million). [ … ]
Technical analysis Trade The News (TTN)
To the publication
Tue, 21.01.2025       Kudelski Group
CH0012268360

Kudelski Group / Key word(s): Miscellaneous Unlocking Efficiency and Reducing Loss: Kudelski IoT’s RecovR and KEYper Systems Team Up to Revolutionize Dealership Key Management in Automotive Retail 21.01.2025 / 17:50 CET/CEST  Phoenix, AZ, Cheseaux-sur-Lausanne, Switzerland, and Harrisburg, NC, January 21, 2025 — Kudels [ … ]
Technical analysis
To the publication
Tue, 21.01.2025       DeFi Technologies Inc.
CA2449161025

Record AUM Milestone: Valour has achieved a historic milestone by surpassing US$1 billion in AUM, with total of US$1.02 billion (C$1.46 billion) as of January 20, 2025. Strategic Global Expansion: Valour is actively working on expanding its reach into emerging markets through MOUs with AsiaNext and SovFi for listing digital asset ETPs in APAC, and [ … ]
Technical analysis
To the publication
Tue, 21.01.2025       MEDICLIN AG
DE0006595101

Offenburg, 21 January 2025 MEDICLIN raises full-year guidance for the 2024 financial year MEDICLIN Aktiengesellschaft (Ticker: MED) announces that it is raising its guidance for the 2024 financial year. Instead of a Group EBIT* between EUR 33.0 and 39.0 million, MEDICLIN now expects a Group EBIT between EUR 48.0 and 54.0 million. The sales forecast [ … ]
Technical analysis
To the publication
Tue, 21.01.2025       Mainz BioMed N.V.
NL0015000LC2

 Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population eAArly DETECT 2 feasibility study designed to validate earlier results on advanced adenomas over a large population of average risk patients Multi-center study expected to complete enrollment in the second [ … ]
Technical analysis
To the publication
Tue, 21.01.2025       Lisata Therapeutics Inc
US1280583022

Company Name: Lisata Therapeutics Inc ISIN: US1280583022   Reason for the research: Initiation of coverage Recommendation: BUY from: 21.01.2025 Target price: USD15.00 Target price on sight of: 12 months Last rating change: - Analyst: Christian Orquera First Berlin Equity Research on 21/01/2025 initiated coverage on Lisata Therap [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
About the newsfeed
#1
Where does the information come from?

The information is provided as part of a content partnership by one of Europe's leading news data providers, the Munich-based EQS Group.

#2
Will editorial changes be made?
The portal site is part of the EQS-Newswire distribution network. The information is provided 'as is'. No editorial adjustments are made. The detailed views are enriched with additional information in order to offer interested investors further research options.
#3
From which news source does the information originate?
As a rule, it is the companies themselves that provide information, either through their own public relations work or via partner agencies. Due to the wide reach of the EQS distribution network and the associated multiplier effects, this service is often used to reach interested parties quickly and in a targeted manner. The EQS Group counts almost all listed companies among its customers.
#4
Are the messages provided in real time?

The data feeds are updated at regular intervals. You can obtain the latest information directly from EQS if required. Simply follow the link below.

#5
Are there plans to expand the scope of the news?

If investor-relevant topics are involved, it is possible to connect additional data providers. In Q1/2024, mwb Research was added to the information offering in the rating area.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Monday, 24.02.2025, Calendar Week 09, 55th day of the year, 310 days remaining until EoY.